Harmony Biosciences Holdings Inc (HRMY) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Industry, else..
 
Harmony Biosciences Holdings inc   (NASDAQ: HRMY)
 

Harmony Biosciences Holdings Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

HRMY Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 12.61 % 14.14 % 10.2 % 10.9 %
Q / Q Revenue Growth (Q3 MRQ) 2.92 % -1.07 % -2.54 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 20.07 % 9.25 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) 3.14 % 2.69 % 2.1 % 2.61 %
Revenue 5 Year Average Growth 40.29 % 7.52 % 8.67 % 13.63 %


HRMY's Growth Comparisons in III. Quarter 2026




Harmony Biosciences Holdings Inc 's 12.61% year on year Revenue increase in the third quarter 2026 to 269 millions, marks slow-down from Harmony Biosciences Holdings Inc 's growth trends, and competes unfavorably to the 14.14% rise in the Major Pharmaceutical Preparations industry, but beating the 10.2% improvement in the Healthcare sector. Observing the third quarter sales growth, both Major Pharmaceutical Preparations industry and Harmony Biosciences Holdings Inc outperformed 10.9% overall market increase.

Comparing the company's Revenue to the second quarter results, sales were higher by 2.92% . On the yearly basis, average annual sales growth for Harmony Biosciences Holdings Inc is 40.29%, while S & P 500's including only Businesses with the third quarter 2026 earnings, average annual sales growth is 13.63% over the past five years.

HRMY Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Rare Neurological Diseases Segment
211.37 %
56.42 %
Total
12.61 %
2.92 %


Growth Rates of HRMY's Income in the third quarter 2026


HRMY Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) -17.24 % 4.19 % 11.09 % 97.6 %
Sequential Operating Income Change (Q3 MRQ) -39.32 % -23.95 % -12.31 % 48.13 %
Y / Y Operating Income Growth (Q3 TTM) -2.78 % 30.85 % 31.01 % 40.67 %
Sequential Operating Income Growth (Q3 TTM) -4.89 % -2.24 % 4.93 % 20.86 %
Operating Income 5 Year Avg. Change 65.12 % 14.12 % 10.27 % 18.8 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) -5.25 % -16.85 % -38.84 % 90.69 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) -36.11 % -26.31 % -63.29 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) -3.81 % 6.33 % 9.9 % 57.33 %
Sequential Income from Cont. Ops. Change (Q3 TTM) -1.47 % -9.97 % -4.66 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - 14.58 % 8.91 % -28.64 %

HRMY Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) -5.25 % -17.47 % -39.18 % 90.69 %
Q / Q Net Income Growth (Q3 MRQ) -36.11 % 21.94 % 11.48 % 27.07 %
Y / Y Net Income Change (Q3 TTM) -3.81 % 5.05 % 15.43 % 57.33 %
Sequential Net Income Change (Q3 TTM) -1.47 % -10.2 % -6.73 % 18.65 %
Net Income 5 Year Avg. Growth - 14.16 % 9.09 % 23.95 %

HRMY's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) -5.68 % -31.09 % -38.84 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) -36.15 % -35.27 % -63.29 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) -4.54 % - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) -1.6 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - -0.46 % 8.91 % -28.64 %



HRMY EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) -6.9 % -31.6 % -39.18 % -28.64 %
Q / Q EPS Net Growth (Q3 MRQ) -36.72 % 7.1 % 11.48 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) -1.95 % 0.05 % 10.56 % 4.93 %
EPS Net 5 Year Avg. Change - 14.16 % 9.09 % 23.95 %



Facing -6.9% year on year income per share decrease in the third quarter, to $ 0.81, Harmony Biosciences Holdings Inc reported smaller declines than the Major Pharmaceutical Preparations industry with -31.6%, and less than -39.18% slide in the Healthcare sector. Slow third quarter 2026 income per share in Major Pharmaceutical Preparations industry and Healthcare sector, were portrayed in Harmony Biosciences Holdings Inc 's results, which underperformed overall market.

Bottom-line fell by -36.72% from the second quarter results. Comparing the annual growth, income per share of 40.29% on average in last five years, to the S & P 500's, including only Businesses with the third quarter 2026 earnings, average yearly income per share growth is 23.95%. Harmony Biosciences Holdings Inc grew faster than the market.

HRMY Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) -29.42 % 26.04 % 44.7 % 48.62 %
Sequential Free Cash Flow Change (Q3 MRQ) -17.03 % -29.98 % -42.72 % 34.18 %
Y / Y Free Cash Flow Change (Q3 TTM) 22.4 % 12.35 % 19.45 % 60.27 %
Sequential Free Cash Flow Change (Q3 TTM) -9.01 % 3.58 % 5.9 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 0.88 % 0.41 % 1.79 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q3 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q3 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q3 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change 7.96 % 29.88 % 6.46 % 1.07 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) - 18.43 % 10.33 % 120.03 %
Sequential Capital Expenditures Change (Q3 MRQ) - -21.14 % -19.33 % 36.87 %
Y / Y Capital Expenditures Change (Q3 TTM) -99.68 % 15.45 % 8.85 % 109.38 %
Sequential Capital Expenditures Change (Q3 TTM) -39.89 % 1.84 % 0.98 % 23.05 %
Capital Expenditures 5 Year Avg. Change 174.2 % 7.88 % 8.63 % 14.2 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.